Reducing healthcare costs and building trust in biosimilar medicines

Abstract

The increasing cost of medicines was highlighted at the Biosimilar Medicines Group (formerly EBG) satellite symposium at the European Association of Hospital Pharmacists' 2016 Vienna conference. Using biosimilars as a way to reduce pharmaceutical expenditure was highlighted as a means to address this problem. However, the necessity of reducing the knowledge gap and building trust in biosimilars is still a key challenge.